New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2013
08:02 EDTSNAK, OUTR, MED, ENZY, RDI, NATR, KIRK, JMBA, PII, THO, GLUU, DCINWedbush to hold a conference
CA Dreamin' Consumer Conference: The NY Edition is being held in New York on December 10.
News For GLUU;KIRK;MED;THO;NATR;OUTR;PII;RDI;SNAK;JMBA;ENZY;DCIN From The Last 14 Days
Check below for free stories on GLUU;KIRK;MED;THO;NATR;OUTR;PII;RDI;SNAK;JMBA;ENZY;DCIN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
06:21 EDTPIIPolaris Industries "on track to generate over $4B in annualized sales"
Polaris CEO Scott Wine stated that Polaris "is on track to generate over $4B in annualized sales."
06:05 EDTPIIPolaris Industries raises 2014 EPS view to $6.30-$6.45 from $6.17-$6.37
Subscribe for More Information
06:02 EDTPIIPolaris Industries reports Q1 EPS $1.19, consensus $1.16
Subscribe for More Information
April 22, 2014
15:32 EDTPIINotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Procter & Gamble (PG), consensus $1.02; Boeing (BA), consensus $1.56; Biogen Idec (BIIB), consensus $2.56; Dow Chemical (DOW), consensus 71c; EMC Corporation (EMC), consensus 35c; Thermo Fisher (TMO), consensus $1.40; Praxair (PX), consensus $1.51; General Dynamics (GD), consensus $1.64; Johnson Controls (JCI), consensus 65c; Norfolk Southern (NSC), consensus $1.15; Reynolds American (RAI), consensus 74c; Delta Air Lines (DAL), consensus 29c; Northrop Grumman (NOC), consensus $2.15; Air Products & Chemicals (APD), consensus $1.35; TD Ameritrade (AMTD), consensus 34c; Ingersoll-Rand (IR), consensus 26c; Dr Pepper Snapple (DPS), consensus 59c; Polaris Industries (PII), consensus $1.16; Ryder System (R), consensus 87c.
08:13 EDTMEDMedifast backs FY14 EPS $1.80-$1.90, consensus $1.83
Backs FY14 revenue $340M-$380M, consensus $256.5M
08:12 EDTMEDMedifast sees Q1 EPS to exceed guidance of 32c-35c, consensus 35c
Expects Q1 revenue to fall within previously announced range of $86M-$88M, consensus $88.1M.
08:11 EDTMEDMedifast sells 11 weight control centers to Medix
Subscribe for More Information
April 21, 2014
15:15 EDTSNAKInventure Foods amends license agreement with TGI Friday’s
Inventure Foods disclosed in a regulatory filing that on April 15 the company entered into a license agreement, effective March 31, with TGI Friday’s that amends and restates their previous agreement, dated April 3, 2000. Material modifications to the prior agreement include: the term was extended beyond the current expiration date of May 31, 2014 to December 31, 2019, with an automatic renewal for an additional five-year period unless the company notifies TGI Friday’s in writing of its intention not to renew; provisions regarding non-refundable advances to be paid by the company to TGI Friday’s were added; provisions regarding escalating royalty rates were added; the sales minimums required by the company were increased; and the geographic scope of the license was expanded into new countries.
14:05 EDTENZYNeptune says '348 patent still valid, to appeal USPTO decision
Neptune Technologies & Bioressources (NEPT) announced that the United States Patent and Trademark Office, or USPTO, recently issued a Right of Appeal Notice in an inter partes reexamination of Neptune's '348 patent. Despite the USPTO's decision, the '348 patent is still valid as Neptune has the right to appeal, which it intends to do, the company said. "Enzymotec (ENZY), in yet another clear attempt to shift focus from the on-going International Trade Commission investigation of its infringement of other Neptune patents, issued a press release addressing the '348 Patent decision. However, Enzymotec failed to highlight that the decision has no impact on the ITC investigation into infringement of Neptune's other composition of matter patents, as well as related federal court actions initiated by Neptune against Enzymotec and its distributors. Furthermore, the decision has no impact on Neptune's license agreements with Rimfrost and Aker BioMarine," said Neptune.
08:09 EDTENZYEnzymotec says USPTO issues final decision, rejects all claims in Neptune patent
Subscribe for More Information
April 17, 2014
09:07 EDTTHOThor Industries acquires RV manufacturer K-Z for $53.4M
Subscribe for More Information
08:29 EDTPIIPolaris Industries has reached attractive entry point, says BMO Capital
After conducting dealer checks in Las Vegas, BMO Capital reports that it was "highly encouraged" by the checks. The firm keeps a $155 price target and Outperform rating on the shares.
April 15, 2014
10:35 EDTMEDMedifast to host analyst day
Analyst day to be held in New York on April 22 at 9 am. Webcast Link
April 10, 2014
16:37 EDTOUTRJana Partners cuts stake in Outerwall to 4.9% from 8.4%
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use